Related Experiment Video
Updated: Aug 4, 2025
07:52
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
9.0K
Molecular imaging of gliomas
Clinical Neuropathology
|March 31, 2023
Summary
Magnetic resonance imaging (MRI) can predict brain tumor molecular features using image-based biomarkers. Advanced MRI techniques show promise in identifying glioma subtypes and heterogeneity, aiding treatment decisions.
Area of Science:
- Neuro-oncology
- Radiology
- Molecular Pathology
Background:
- Molecular markers are crucial for classifying and grading primary brain tumors, guiding treatment and prognosis.
- Key markers include isocitrate dehydrogenase (IDH) mutation status, 1p/19q codeletion, O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and CDKN2A/B homozygous deletion.
- Magnetic resonance imaging (MRI) traditionally aids tumor detection and treatment planning but is emerging as a tool for assessing molecular features.
Purpose of the Study:
- To explore the potential of MRI-based biomarkers for predicting molecular characteristics of gliomas.
- To highlight the role of specific MRI signs, like the T2/FLAIR mismatch, in identifying distinct glioma subtypes.
- To discuss the application of multiparametric MRI and machine learning in predicting molecular markers and understanding glioma heterogeneity.
Main Methods:
- Review of studies investigating the correlation between MRI findings and molecular markers in brain tumors.
- Analysis of the diagnostic performance of the T2/FLAIR mismatch sign for specific glioma subtypes.
- Evaluation of multiparametric MRI combined with machine learning for predicting molecular features.
Main Results:
- The T2/FLAIR mismatch sign demonstrates high specificity (up to 100%) in identifying IDH-mutant, 1p/19q non-codeleted astrocytomas.
- Multiparametric MRI, particularly when integrated with machine learning, achieves high accuracy in predicting various molecular markers.
- MRI shows potential in assessing tumor heterogeneity and anticipating molecular composition changes.
Conclusions:
- MRI-based biomarkers offer a non-invasive method for inferring molecular characteristics of gliomas.
- Advanced MRI techniques, including multiparametric approaches and machine learning, are valuable for glioma classification and personalized treatment.
- Future applications may involve real-time monitoring of glioma molecular evolution and heterogeneity.
